Giuseppina D’Agostino is the Founder and Director of IP Osgoode, the IP Intensive Program, and the IP Osgoode Innovation Clinic, the Founder and Editor-in-Chief of
American IP scholar Mark Lemley aptly characterized the dynamic relationship between IP and competition law as a swinging pendulum, in which antitrust enforcement of IP
On October 23rd and 24th, inventors, law students, lawyers, patent agents, patent portfolio managers, policy analysts, Canadian Intellectual Property Office’s (CIPO) patent examiners and other
On September 23, Canada’s Competition Bureau (“the Bureau”) announced landmark guidelines regarding the consideration of pharmaceutical patent litigation settlements under Canada’s competition law framework. The
Originating back in 2006, the litigation between Pfizer and Apotex over Pfizer’s blockbuster drug, Lipitor, has been long and arduous. With many twists and turns
Professor Giuseppina D’Agostino, Founder and Director of the Intellectual Property Law & Technology Group (IP Osgoode) at Osgoode Hall Law School, stirred up the IP
